← All educational resources

Medications and the Nutrients They Drain

2026-11-10

Same post, two depths. Switch any time; the research version has the enzyme names, lab markers, and doses. Written from a research and education perspective: a model of what may be going on and what the published literature suggests would address it if the model is right, not medical advice or a treatment plan.

Medications are the single most common cause of nutrient shortfalls I come across, and almost nobody is told at the pharmacy counter. A drug that lowers stomach acid lowers B12, iron, magnesium, and zinc. A drug that lowers blood sugar lowers B12. A drug that lowers cholesterol lowers CoQ10. The drug is often doing its job well. The deficiency it creates is a separate problem, it builds slowly, and it is usually blamed on something else.

This page is a lookup table: find your medication, see what it drains, and see what the research suggests for watching and replacing it. It is not a reason to stop a medication. It is a reason to test and, with your provider, to replace what is being lost.

How to use it: the "what to watch" column is the lab from the Lab Guide here; the "what the research suggests" column is the nutrient and form from the Nutrient Guide here. Timing notes tell you when a supplement has to be taken apart from the drug so neither blocks the other.

Stomach acid and digestion

Medication Drains Why What to watch What the research suggests
Proton pump inhibitors (omeprazole, pantoprazole, esomeprazole, lansoprazole) B12, magnesium, iron, zinc, calcium, vitamin C, possibly beta-carotene Acid is needed to release B12 from food, to keep iron soluble, and to run the magnesium channel in the gut MMA, RBC magnesium, ferritin and saturation, plasma zinc; yearly Sublingual hydroxo/adenosyl B12; magnesium glycinate; iron only by ferritin; zinc balanced with copper; and a real conversation about whether the PPI is still needed (see the stomach acid post here)
H2 blockers (famotidine) B12, iron, zinc (milder than PPIs) Same mechanism, less complete MMA, ferritin As above, lower priority
Antacids (calcium carbonate, aluminum, magnesium hydroxide) Iron, folate, phosphate (aluminum); may raise magnesium Bind minerals in the gut Ferritin if daily use Take iron and other minerals two hours apart
Bile acid sequestrants (cholestyramine, colestipol) Vitamins A, D, E, K, folate, iron, zinc, magnesium Bind fat and the fat-soluble vitamins with it 25-OH-D, INR or ucOC, retinol Fat-soluble vitamins taken 4 hours apart from the drug
Orlistat Vitamins A, D, E, K, beta-carotene Blocks fat absorption 25-OH-D Fat-soluble multivitamin at bedtime, apart from the drug

Blood sugar

Medication Drains Why What to watch What the research suggests
Metformin B12 (in up to 30 percent of long-term users), folate; raises homocysteine Blocks the calcium-dependent step of B12 absorption in the ileum MMA and holoTC yearly; homocysteine Hydroxo/adenosyl B12 1,000 mcg; the neuropathy blamed on diabetes is sometimes the B12
Sulfonylureas, SGLT2 inhibitors Minor; SGLT2 drugs raise magnesium and lose some B vitamins in urine RBC magnesium Usually nothing specific
Insulin Magnesium, potassium (shifts into cells) Insulin drives both into cells RBC magnesium Magnesium if low

Cholesterol and heart

Medication Drains Why What to watch What the research suggests
Statins (atorvastatin, rosuvastatin, simvastatin) CoQ10, vitamin K2 (MK-4), possibly vitamin D and selenium; lower omega-3 slightly Block the enzyme at the branch point that also makes CoQ10 and the carrier for K2 Muscle symptoms, CK if aching; omega-3 index Ubiquinol 100 to 200 mg with a meal (the muscle-ache evidence is mixed but the depletion is not); K2 MK-7
Loop diuretics (furosemide, torsemide) Thiamine, magnesium, potassium, zinc, calcium, B6 Washed out in urine Whole-blood TPP, RBC magnesium, potassium Benfotiamine or thiamine; magnesium; potassium by prescriber
Thiazides (hydrochlorothiazide, chlorthalidone) Magnesium, potassium, zinc, sodium; raise calcium Renal loss RBC magnesium, potassium, zinc Magnesium; zinc with copper
ACE inhibitors and ARBs Zinc; raise potassium Zinc lost in urine with ACE inhibitors Zinc, potassium Zinc balanced with copper; no potassium supplements without prescriber
Beta blockers CoQ10, melatonin Block CoQ10-dependent enzymes; suppress nighttime melatonin release Sleep quality Ubiquinol; melatonin 0.5 to 1 mg if sleep is affected
Digoxin Magnesium, thiamine, calcium Renal loss; the magnesium matters for toxicity RBC magnesium Magnesium (low magnesium makes digoxin dangerous)
Hydralazine B6 Binds the active form Plasma P5P P5P 25 to 50 mg
Warfarin Vitamin K (by design) Blocks K recycling INR Keep intake steady, do not start or stop K-containing supplements without the prescriber
Aspirin, long term Vitamin C, folate, iron (through bleeding) Gut lining, excretion Ferritin Vitamin C; iron by ferritin

Hormones

Medication Drains Why What to watch What the research suggests
Combined oral contraceptives B6, folate, B12, B2, vitamin C, zinc, magnesium, selenium; raise copper, iron, and vitamin A Estrogen raises copper-binding protein and shifts B6 metabolism Plasma P5P, RBC folate, zinc and copper together, homocysteine P5P; folinic acid or methylfolate; magnesium; zinc (ratio matters: copper is already high on the pill)
Hormone replacement (oral estrogen) Similar to the pill; raises copper and SHBG Same Copper and zinc As above
Corticosteroids (prednisone, inhaled and nasal at high doses) Calcium, vitamin D, potassium, magnesium, zinc, vitamin C, chromium; protein (muscle) Raise excretion, block absorption, break down tissue 25-OH-D, bone density on long courses, potassium Vitamin D with K2 and magnesium; protein; calcium from food
Levothyroxine None directly, but absorption is blocked by calcium, iron, soy, coffee, and PPIs TSH, free T3 Take on an empty stomach, 4 hours apart from iron and calcium
Spironolactone Raises potassium; may lower zinc Potassium No potassium supplements

Antibiotics and antimicrobials

Medication Drains Why What to watch What the research suggests
Any broad-spectrum antibiotic Vitamin K2, biotin, B vitamins made by gut bacteria; disrupts the microbiome Kills the producers None routinely A course of probiotics after, not during; K2 and B complex if a long course
Tetracyclines (doxycycline, minocycline) Calcium, magnesium, iron, zinc (and the drug binds them) Chelation in the gut Take minerals 2 to 3 hours apart from the drug
Fluoroquinolones (ciprofloxacin, levofloxacin) Magnesium, iron, zinc, copper; damage mitochondria and collagen Chelate the metals the collagen enzymes need; mitochondrial toxicity Tendon pain, fatigue, nerve symptoms Avoid in hypermobile people unless no alternative; magnesium during and after; NAC and vitamin E plus selenium have early prevention data; no iron or copper during the acute phase
Trimethoprim-sulfamethoxazole (Bactrim) Folate Blocks the folate enzyme RBC folate if long term Folinic acid
Isoniazid B6, B3 Binds B6; blocks niacin synthesis Neuropathy P5P is standard with it
Metronidazole Possibly B vitamins, taste changes from zinc Zinc if taste is affected
Antifungals (fluconazole, ketoconazole) Ketoconazole lowers vitamin D activation and cortisol 25-OH-D Vitamin D

Pain, mood, and nerves

Medication Drains Why What to watch What the research suggests
NSAIDs (ibuprofen, naproxen), long term Iron (bleeding), folate, vitamin C; damage the gut lining Mucosal injury Ferritin, stool calprotectin Iron by ferritin; zinc-carnosine and glutamine for the lining
Acetaminophen, regular use Glutathione Consumed in clearing it GGT NAC and glycine; never combine with alcohol
Opioids Nothing directly; constipation blocks every mineral's exit route and raises recycled estrogen Bowel function Magnesium citrate, fiber
SSRIs and SNRIs Sodium (hyponatremia in older adults), possibly folate and B12 utilization; folate status predicts response Sodium in older adults Methylfolate has trial data as an add-on when folate is low
Tricyclics B2, CoQ10 B2, ubiquinol
Anticonvulsants (valproate, carbamazepine, phenytoin, phenobarbital) Folate, vitamin D, biotin, carnitine (valproate), vitamin K, B12, calcium Induce liver enzymes that clear vitamins; valproate blocks carnitine RBC folate, 25-OH-D, carnitine (valproate), bone density Folinic acid (not folic acid; some anticonvulsants interact), vitamin D with K2, biotin, L-carnitine with valproate
Gabapentin, pregabalin Minor
Lithium Raises calcium, lowers thyroid function and sodium handling Calcium, thyroid, sodium Prescriber-managed
Antipsychotics Raise insulin resistance; may lower B2 and CoQ10 Fasting insulin, lipids Metabolic monitoring
Nitrous oxide (dental, surgical, recreational) B12, permanently inactivates the enzyme Oxidizes the cobalt in B12 MMA, homocysteine after any exposure if symptoms Hydroxocobalamin before and after planned exposure; this is the one that causes spinal cord damage in B12-marginal people

Other common ones

Medication Drains Why What to watch What the research suggests
Methotrexate Folate (by design), B12 utilization Blocks the folate enzyme RBC folate, CBC Folinic acid on the days the prescriber sets; never on the methotrexate day without instruction
Sulfasalazine Folate Blocks absorption and the enzyme RBC folate Folinic acid
Colchicine B12 Damages the absorbing cells MMA B12
Allopurinol None major
Bisphosphonates None, but need calcium and D to work 25-OH-D Vitamin D with K2 and magnesium
Chemotherapy (platinum, taxanes, 5-FU) Magnesium (platinum), B vitamins, glutathione, many others Renal loss, mucosal damage RBC magnesium Oncology-directed; never add antioxidants during active treatment without the oncologist
Alcohol (a drug, in this table on merit) Thiamine, folate, B6, B12, magnesium, zinc, vitamin A, vitamin C, selenium, glutathione Blocks absorption, raises loss, consumes glutathione, poisons the gut lining Whole-blood TPP, RBC folate, RBC magnesium, GGT Thiamine first (before any glucose), then the rest; less alcohol
Caffeine, heavy use Calcium, magnesium, iron (if with meals), B vitamins through urine Diuretic; tannins bind iron Coffee apart from iron-containing meals
Smoking and nicotine Vitamin C (needs about 35 mg more a day), folate, B12, vitamin E, zinc, selenium Oxidative load Plasma ascorbate Vitamin C; stopping

The patterns worth noticing

Three drugs, one deficiency. A PPI plus metformin plus a vegetarian diet is a B12 deficiency waiting to be found. A thiazide plus a PPI plus daily coffee is a magnesium deficiency. The pill plus a statin plus a low-fat diet is a CoQ10, B6, and zinc picture with copper running high.

The deficiency gets blamed on the disease. Metformin's neuropathy is often B12. Statin myalgia is often CoQ10. The fatigue on a PPI is often magnesium and B12. Prednisone's weakness is partly protein and potassium. Anticonvulsant bone loss is vitamin D and K. Testing separates the drug effect from the disease effect, and the fix for the deficiency does not require stopping the drug.

Timing solves half of it. Levothyroxine, tetracyclines, fluoroquinolones, and bisphosphonates all need a gap of 2 to 4 hours from iron, calcium, magnesium, and zinc. Fat-soluble vitamins need a gap from sequestrants and orlistat. Most of the rest can be taken together.

Do not stop a drug because of this page. Every one of these is a conversation with the prescriber. The point is to test what the drug is known to drain, replace it in the right form, and recheck.

Educational content written from a research perspective, not medical advice. I am a PhD scientist, not a physician, and I do not diagnose, treat, cure, or prevent disease. Medication decisions belong with your prescriber; several supplements here interact with the drugs they are listed next to (vitamin K with warfarin, potassium with ACE inhibitors and spironolactone, folate with methotrexate, antioxidants with chemotherapy) and must be discussed first.

Framing

Drug-induced nutrient depletion is well documented for individual agents and almost never assessed in practice, partly because the deficiency develops over months to years, partly because its presentation is attributed to the underlying disease, and partly because routine panels do not include the markers that would detect it. This page is a reference by drug class: the nutrients affected, the mechanism, the monitoring assay from the Lab Guide here, and the repletion approach from the Nutrient Guide here. It is written for discussion with the prescriber and is not a reason to alter therapy.

Mechanistic categories, which recur across the table:

  • Absorption: gastric acid suppression (B12 release from food protein, non-heme iron solubility, TRPM6-dependent magnesium uptake), luminal chelation (tetracyclines, fluoroquinolones, bisphosphonates with divalent cations), bile acid sequestration (fat-soluble vitamins), ileal transport inhibition (metformin and the calcium-dependent cubam step).
  • Renal loss: loop and thiazide diuretics (magnesium, potassium, thiamine, zinc), SGLT2 inhibitors, cisplatin, aminoglycosides.
  • Enzyme inhibition or cofactor antagonism: DHFR (methotrexate, trimethoprim, pyrimethamine), HMG-CoA reductase (CoQ10, dolichol, isoprenoid-dependent K2 synthesis), VKORC1 (warfarin), PLP binding (isoniazid, hydralazine, penicillamine, cycloserine), cobalt oxidation (nitrous oxide).
  • Induction of catabolism: CYP-inducing anticonvulsants (vitamin D, folate, vitamin K), glucocorticoids (protein, calcium).
  • Consumption: acetaminophen (glutathione), alcohol (thiamine, glutathione, folate), oxidative stressors.
  • Microbiome disruption: antibiotics (vitamin K2, biotin, B vitamins, short-chain fatty acids), PPIs (SIBO, which consumes thiamine and B12 and generates propionate).

Acid suppression and gastrointestinal agents

Drug Nutrients Mechanism Monitoring Repletion and timing
Proton pump inhibitors B12 (OR about 1.65 for deficiency with over 2 years' use), magnesium (FDA warning 2011; hypomagnesemia refractory to oral repletion in a subset), non-heme iron, zinc, calcium, vitamin C, beta-carotene Loss of acid-pepsin release of protein-bound B12; TRPM6 requires luminal acidity; Fe(III) insoluble at neutral pH; SIBO secondary to hypochlorhydria MMA and holoTC annually; RBC magnesium; ferritin and saturation; plasma zinc; consider breath test if bloating Sublingual hydroxocobalamin and adenosylcobalamin; magnesium glycinate (switching to an H2 blocker often resolves refractory hypomagnesemia); iron by ferritin; zinc with copper; periodic reassessment of indication and deprescribing where appropriate
H2 receptor antagonists B12, iron, zinc (less than PPIs) Partial acid suppression MMA, ferritin As above
Antacids Iron, folate, phosphate (aluminum-containing); magnesium excess (magnesium hydroxide) Luminal binding and pH Ferritin with chronic use Separate minerals by 2 hours
Bile acid sequestrants (cholestyramine, colesevelam) Vitamins A, D, E, K; folate; iron; zinc; magnesium; also bind levothyroxine, digoxin Sequestration of bile acid micelles 25-OH-D, PIVKA-II or INR, retinol Fat-soluble vitamins and other drugs 1 hour before or 4 hours after
Orlistat Vitamins A, D, E, K, beta-carotene Lipase inhibition 25-OH-D Fat-soluble multivitamin at bedtime
Laxatives (stimulant, chronic) Potassium, magnesium, calcium Secretory loss Electrolytes Prescriber review

Glucose-lowering agents

Drug Nutrients Mechanism Monitoring Repletion and timing
Metformin B12 (prevalence of deficiency 6 to 30 percent, dose- and duration-dependent), folate; raises homocysteine; lowers holoTC before serum B12 Calcium-dependent cubam (IF-B12 receptor) interference; altered ileal motility and bacterial overgrowth MMA and holoTC at baseline and annually (ADA 2017 guidance supports periodic B12 assessment); homocysteine Hydroxocobalamin and adenosylcobalamin 1,000 to 2,000 mcg sublingual; calcium supplementation partially reverses the absorption defect; neuropathy attributed to diabetes should prompt MMA
SGLT2 inhibitors Raise serum magnesium; urinary loss of water-soluble vitamins is modest Osmotic diuresis RBC magnesium Usually none
Thiazolidinediones Bone loss (calcium, vitamin D context) PPAR-gamma shift from osteoblast to adipocyte lineage Bone density Vitamin D with K2
Insulin Intracellular shift of potassium, magnesium, phosphate Na/K-ATPase activation RBC magnesium, potassium Magnesium where low

Cardiovascular agents

Drug Nutrients Mechanism Monitoring Repletion and timing
Statins CoQ10 (plasma falls 16 to 54 percent), vitamin K2 (MK-4 synthesis requires geranylgeranyl-PP from the mevalonate pathway), dolichol, heme A, selenoprotein synthesis (isopentenyl-tRNA); modest vitamin D and omega-3 effects HMG-CoA reductase inhibition upstream of the farnesyl-PP branch point CK and symptoms; omega-3 index; CoQ10 level where available Ubiquinol 100 to 200 mg with a fat-containing meal (RCTs on myalgia are mixed; the biochemical depletion is consistent); K2 MK-7 100 to 200 mcg; SLCO1B1 genotype where myalgia recurs
Loop diuretics Thiamine (urinary loss proportional to diuresis; prevalence of deficiency in heart failure on furosemide reported up to 90 percent in some series), magnesium, potassium, calcium, zinc, pyridoxine Inhibition of NKCC2 with downstream reduced paracellular reabsorption Whole-blood TDP or transketolase; RBC magnesium; potassium Thiamine 100 to 300 mg or benfotiamine (several small trials improve ejection fraction in thiamine-deficient heart failure); magnesium; potassium per prescriber
Thiazide and thiazide-like diuretics Magnesium, potassium, zinc, sodium; raise calcium and uric acid NCC inhibition; distal magnesium wasting RBC magnesium, potassium, zinc Magnesium; zinc with copper
ACE inhibitors Zinc (urinary loss); raise potassium Zinc-chelating sulfhydryl (captopril) and renal effects Plasma zinc, potassium Zinc with copper; no potassium supplementation without prescriber
Angiotensin receptor blockers Raise potassium; minor zinc effect Potassium
Beta blockers CoQ10 (inhibition of CoQ10-dependent enzymes), melatonin (suppressed nocturnal secretion via beta-1 blockade of pineal synthesis) Receptor-mediated Sleep quality Ubiquinol; melatonin 0.5 to 1 mg has RCT support for beta-blocker-associated insomnia
Digoxin Magnesium, thiamine, calcium Renal loss; hypomagnesemia potentiates toxicity RBC magnesium Magnesium repletion is standard
Hydralazine Pyridoxine Forms a hydrazone with PLP Plasma PLP P5P 25 to 50 mg
Warfarin Vitamin K (therapeutic target) VKORC1 inhibition INR Consistent intake; no initiation or cessation of K-containing supplements without prescriber; CYP2C9 and VKORC1 genotype informs dosing
Aspirin, chronic Vitamin C, folate, iron (occult loss) Mucosal injury; competition for ascorbate uptake Ferritin Ascorbate; iron by ferritin
Amiodarone Thyroid (iodine load), vitamin D Iodine content, CYP effects Thyroid panel, 25-OH-D Endocrine monitoring

Hormonal agents

Drug Nutrients Mechanism Monitoring Repletion and timing
Combined oral contraceptives Pyridoxine (altered tryptophan metabolism and PLP binding), folate, B12 (lower serum without clear tissue deficiency), riboflavin, ascorbate, zinc, magnesium, selenium; raise copper, ceruloplasmin, iron, retinol, SHBG, and CRP Estrogen induction of hepatic proteins and altered renal handling Plasma PLP, RBC folate, copper and zinc together, homocysteine, hs-CRP P5P; folinic acid or methylfolate (preconception in particular); magnesium; zinc (copper is already elevated, so the ratio is the target); interpret copper and ceruloplasmin as estrogen-raised
Oral estrogen replacement As above; raises SHBG and copper; transdermal estrogen has less hepatic effect First-pass hepatic effect Copper, zinc, SHBG As above
Glucocorticoids (systemic; high-dose inhaled) Calcium (reduced absorption, increased excretion), vitamin D, potassium, magnesium, zinc, ascorbate, chromium, protein (proteolysis), vitamin K Reduced intestinal calcium transport, renal loss, catabolism 25-OH-D, bone density on courses over 3 months, potassium, glucose Vitamin D with K2 and magnesium; calcium from food; protein 1.2 to 1.6 g/kg; bone protection per guideline
Levothyroxine None depleted; absorption reduced 20 to 40 percent by calcium, iron, soy, coffee, PPIs, sucralfate, bile acid sequestrants Luminal binding and pH TSH, free T3 Empty stomach, 4 hours from iron and calcium, consistent timing; consider liquid or gel formulations with PPIs
Spironolactone, eplerenone Raise potassium; spironolactone may lower zinc Aldosterone antagonism Potassium No potassium supplementation
GnRH agonists, aromatase inhibitors Bone (calcium, vitamin D context) Estrogen deprivation Bone density, 25-OH-D Vitamin D with K2, magnesium, resistance training

Antimicrobials

Drug Nutrients Mechanism Monitoring Repletion and timing
Broad-spectrum antibiotics Vitamin K2 (menaquinone-producing taxa), biotin, folate, B12, riboflavin, short-chain fatty acids Microbiome depletion None routinely; INR if anticoagulated Post-course probiotics (not during, for most strains); K2 and B complex for prolonged courses
Tetracyclines Calcium, magnesium, iron, zinc (bidirectional: drug absorption is also reduced) Luminal chelation Minerals 2 to 3 hours apart
Fluoroquinolones Magnesium, iron, zinc, copper (chelation); mitochondrial injury (mtDNA, ROS); collagen degradation (MMP induction, hydroxylase inhibition) Chelation of divalent cations; topoisomerase effects on mtDNA; iron chelation inhibiting Fe/2-OG dioxygenases Tendon symptoms, fatigue, neuropathic symptoms; RBC magnesium Avoid in connective tissue laxity absent clear indication (FDA boxed warning 2008, expanded 2018); magnesium repletion during and after; NAC and vitamin E plus selenium have preclinical and one small human prevention trial; withhold iron and copper during the acute phase (Fenton chemistry); minerals 2 to 6 hours apart from doses
Trimethoprim, trimethoprim-sulfamethoxazole Folate Bacterial and (weakly) human DHFR inhibition RBC folate, CBC with prolonged use Folinic acid (bypasses DHFR) rather than folic acid
Pyrimethamine Folate DHFR inhibition CBC Folinic acid is standard
Isoniazid Pyridoxine, niacin PLP hydrazone formation; impaired tryptophan to niacin conversion Neuropathy P5P 25 to 50 mg co-prescribed as standard
Cycloserine, penicillamine Pyridoxine PLP binding Plasma PLP P5P
Metronidazole Possible B vitamin effects; dysgeusia Zinc if dysgeusia persists
Ketoconazole, high-dose fluconazole Vitamin D (CYP27B1 inhibition), cortisol and testosterone synthesis CYP inhibition 25-OH-D Vitamin D
Aminoglycosides, amphotericin Magnesium, potassium, calcium Renal tubular loss Electrolytes, RBC magnesium Repletion per prescriber

Analgesic, psychiatric, and neurologic agents

Drug Nutrients Mechanism Monitoring Repletion and timing
NSAIDs, chronic Iron (occult blood loss), folate, ascorbate; mucosal injury raising permeability COX inhibition, mucosal injury Ferritin, fecal calprotectin Iron by ferritin; zinc-carnosine and glutamine for mucosal repair
Acetaminophen, regular Glutathione, cysteine; methionine and glycine conjugation substrates NAPQI detoxification consumes GSH GGT, liver enzymes NAC and glycine; absolute avoidance with alcohol
Opioids Secondary: constipation impairs mineral and conjugate excretion; hypogonadism with chronic use Mu-receptor effects on motility and the HPG axis Bowel function, testosterone Magnesium citrate, fiber; endocrine review
SSRIs, SNRIs Sodium (SIADH, particularly in older adults); folate status predicts response and methylfolate augmentation has RCT support; possible effects on B12 utilization; bone density with long use Serotonergic effects on ADH Sodium in older adults; RBC folate L-methylfolate 7.5 to 15 mg has augmentation data in treatment-resistant depression with low folate; not combined with tryptophan or 5-HTP without oversight
Tricyclics Riboflavin, CoQ10 Inhibition of riboflavin metabolism Riboflavin, ubiquinol
Enzyme-inducing anticonvulsants (phenytoin, carbamazepine, phenobarbital, primidone) Folate, vitamin D (CYP24A1 induction), vitamin K, biotin, B12, calcium; bone loss Hepatic enzyme induction, impaired absorption RBC folate, 25-OH-D, bone density, homocysteine Folinic acid (folic acid can lower phenytoin levels; folinic acid is the preferred form); vitamin D with K2; biotin
Valproate Carnitine (formation of valproylcarnitine and inhibition of carnitine transport), folate, biotin, vitamin D, zinc, selenium Carnitine conjugation and OCTN2 inhibition Plasma free carnitine, acylcarnitine profile, RBC folate, ammonia L-carnitine 50 to 100 mg/kg (standard for valproate-associated hyperammonemia and recommended prophylactically in several guidelines); folinic acid; biotin
Gabapentinoids Minimal
Lithium Raises calcium (parathyroid effect), lowers thyroid function, affects sodium and water handling, may lower folate utilization Calcium, PTH, thyroid panel, renal function Prescriber-managed
Antipsychotics Insulin resistance, dyslipidemia; possible riboflavin and CoQ10 effects Metabolic receptor effects Fasting insulin, lipids, A1c Metabolic monitoring per guideline
Nitrous oxide Cobalamin (irreversible oxidation of cob(I)alamin on methionine synthase) Cobalt oxidation MMA and homocysteine after exposure when symptomatic; preoperative B12 status in at-risk patients Hydroxocobalamin before and after planned anesthesia in marginal patients; recreational use produces subacute combined degeneration
Levodopa Raises homocysteine (COMT methylation of levodopa consumes SAMe); B6, folate, B12 SAMe consumption Homocysteine Folate, B12, B6 (carbidopa limits the historical B6 problem)
Methylphenidate, amphetamines Appetite suppression with secondary intake deficits; zinc and iron status affect response Ferritin, zinc Iron and zinc by labs

Immunologic, rheumatologic, oncologic, and other

Drug Nutrients Mechanism Monitoring Repletion and timing
Methotrexate Folate (therapeutic target), B12 utilization; raises homocysteine DHFR inhibition RBC folate, CBC, liver enzymes Folinic acid 5 to 15 mg or folic acid per rheumatology protocol on non-methotrexate days; folinic acid is the rescue form in oncology dosing
Sulfasalazine Folate Inhibits DHFR and intestinal folate transport RBC folate Folinic acid
Colchicine B12 (ileal mucosal effect), beta-carotene Mucosal toxicity MMA B12
Hydroxychloroquine Minimal
Bisphosphonates None depleted; require calcium and vitamin D for efficacy; chelate minerals in the gut Luminal binding 25-OH-D Vitamin D with K2 and magnesium; separate minerals by 30 minutes or more per label
Platinum chemotherapy Magnesium (renal wasting, often persistent), potassium, calcium Tubular injury RBC magnesium Magnesium repletion per oncology
5-fluorouracil, capecitabine Thiamine (rare Wernicke's), folate pathway Thiamine utilization Oncology-directed
Antioxidant supplementation during cytotoxic therapy Context-dependent May blunt ROS-dependent cytotoxicity Oncologist directs; not self-initiated
Ethanol Thiamine (absorption, phosphorylation, storage), folate, pyridoxine, B12, magnesium, zinc, retinol, ascorbate, selenium, glutathione; raises iron absorption Multiple: transporter inhibition, hepatic storage, renal loss, GSH consumption, CYP2E1 induction Whole-blood TDP, RBC folate, RBC magnesium, GGT, ferritin Thiamine before any glucose load; then folate, magnesium, zinc; reduction of intake is the primary lever
Caffeine, high intake Calcium and magnesium (urinary), iron (tannin binding with meals), modest B vitamin loss Diuresis, chelation Separate from iron-containing meals; CYP1A2 slow metabolizers limit afternoon intake
Tobacco and nicotine Ascorbate (requirement raised by about 35 mg/day), folate, B12, vitamin E, zinc, selenium, beta-carotene (avoid supplemental beta-carotene in smokers: increased lung cancer in two trials) Oxidative load, altered metabolism Plasma ascorbate Ascorbate; cessation

Interpretive patterns

Stacked depletion. PPI plus metformin plus plant-based diet converges on B12. Thiazide plus PPI plus high caffeine converges on magnesium. Oral contraceptive plus statin plus low-fat diet converges on B6, zinc, and CoQ10 with copper elevated. The combination, not any single agent, is what crosses the threshold.

Attribution error. Metformin-associated neuropathy is frequently B12 deficiency; statin myalgia is in part CoQ10 depletion; PPI-associated fatigue and arrhythmia are frequently magnesium; glucocorticoid myopathy is partly protein and potassium; anticonvulsant bone loss is vitamin D and K. Testing distinguishes drug-induced deficiency from disease progression, and repletion does not require drug discontinuation.

Timing. Levothyroxine, tetracyclines, fluoroquinolones, and bisphosphonates require separation from divalent cations (2 to 4 hours); fat-soluble vitamins require separation from sequestrants and orlistat (4 hours); most other combinations are compatible.

Drug-nutrient interactions in the other direction. Vitamin K with warfarin, potassium with RAAS blockade and potassium-sparing diuretics, folic acid with methotrexate timing, tryptophan and 5-HTP with serotonergic drugs, high-dose niacin with statins (myopathy), St John's wort with CYP3A4 substrates, calcium and iron with levothyroxine, and antioxidants during cytotoxic therapy each require prescriber coordination before any change.

Educational and research content, not medical advice. The author holds a PhD in cellular and molecular nutrition, is not a licensed physician, and does not diagnose, treat, cure, or prevent disease. Medication decisions belong with the prescriber; several agents listed interact with the supplements named beside them and require coordination before any change.